Preo Pharma ApS: Financial statements 2021
CVR: 41191007
Preo Pharma ApS (CVR 41191007) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 294,880 and a net result of DKK 188,655 compared with DKK -120,084 the year before. Equity amounted to DKK 108,571. The solvency ratio was 28.8%.
- Gross Profit
- 294,880 kr.
- Profit/Loss
- 188,655 kr.
- Equity
- 108,571 kr.
- Total Assets
- 376,735 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 295 t. | 189 t. | 109 t. | - |
| 2020 | - | -161 t. | -120 t. | -80 t. | - |
Find more companies like Preo Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Preo Pharma ApS has published its interim report for the period February 24, 2020 – December 31, 2020.
As of February 24, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Preo Pharma ApS.
About Preo Pharma ApS
Preo Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2020 and dissolved in 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity amounted to DKK 54,270.
